BD to Announce Financial Results for its Third Quarter of Fiscal 2024
BD (Becton, Dickinson and Company) will announce its financial results for the third quarter of fiscal year 2024 on August 1, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BD (Becton, Dickinson and Company) will announce its financial results for the third quarter of fiscal year 2024 on August 1, 2024. The report will be released at 6:30 a.m. Eastern Time (ET) and will be available on the company's investor relations website. The announcement will include summary financial information for the quarter ending June 30, 2024. Following the release, BD management will host an audio webcast at 8 a.m. ET to discuss the results, operations, and strategy updates. A replay of the webcast will be accessible on the same website shortly after the call.
Positive
- Scheduled financial results announcement indicates transparency and commitment to keeping investors informed.
- Planned webcast provides an opportunity for investors to gain insight into company operations and strategy.
Negative
- None.
Details
News Market Reaction – BDX
The recorded move for BDX in the trading session of this news was -0.17%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BD management will host an audio webcast at 8 a.m. ET on August 1, 2024 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-2024-302188455.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.